ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
82 hedge funds and large institutions have $30.5M invested in Oncternal Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less capital invested
Capital invested by funds: $56.8M → $30.5M (-$26.3M)
Holders
82
Holding in Top 10
–
Calls
$223K
Puts
$118K
Top Buyers
| 1 | +$531K | |
| 2 | +$226K | |
| 3 | +$203K | |
| 4 |
Goldman Sachs
New York
|
+$143K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$134K |
Top Sellers
| 1 | -$718K | |
| 2 | -$686K | |
| 3 | -$674K | |
| 4 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$473K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$391K |